Our results showed that the methylation of FAM156B, PPP1R3F, and PIH1D3 genes in blood leukocytes is significantly associated with colorectal cancer (CRC) risk and may be potential biomarkers for CRC risk. This evidence concerns the gene DNAAF6 and colorectal carcinoma.